Date of submission of the HTAC Recommendation: 11 June 2026Date of notification to HTAC on the SOH decision: 30 July 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on ezetimibe [10 mg tablet] for the treatment of hyperlipidemia as an adjunct to maximally-tolerated statin therapy through Department of Health (DOH) continue reading : HTA Council Final Recommendation on ezetimibe [10 mg tablet] for the treatment of hyperlipidemia (with Secretary of Health Decision)